Finance

UK's Pets at Home reaffirms profit forecast, expects sales growth revival at retail unit

Published by Global Banking & Finance Review

Posted on March 31, 2026

2 min read

· Last updated: April 1, 2026

Add as preferred source on Google
UK's Pets at Home reaffirms profit forecast, expects sales growth revival at retail unit
Global Banking & Finance Awards 2026 — Call for Entries

March 31 (Reuters) - British pet care retailer Pets at Home reaffirmed its annual profit forecast on Tuesday after its turnaround plan helped revive sales growth at its retail business, which had been

Pets at Home Confirms Profit Forecast, Expects Retail Sales Bounce Back

Pets at Home's Financial Performance and Turnaround Strategy

March 31 (Reuters) - British pet care retailer Pets at Home reaffirmed its annual profit forecast on Tuesday after its turnaround plan helped revive sales growth at its retail business, which had been hit by falling demand for discretionary pet products.

The company, which also offers grooming and veterinary services, has been working to fix product ranges and restore execution in its pet food and accessories business, while its fast-growing veterinary division continues to underpin profits.

Leadership Changes and Market Reaction

Pets at Home shook up its leadership with a new CEO and CFO to lead the turnaround, following a challenging 2025 marked by profit warnings.

Shares rose nearly 5% in early trading.

Key Highlights of Turnaround Plan

  • Cost-Savings and Price Investments
    Pets at Home said it has completed its 20-million-pound($26.39 million) cost-savings target and implemented price investments as part of its turnaround plan focused on product, price, execution and cost.
  • Retail Business Performance
    The retail business returned to positive like-for-like sales growth in the second half, it said, with fourth-quarter performance improving sequentially.
  • Profit Expectations for Retail and Veterinary Divisions
    The company expects the retail business to deliver underlying profit of about 30 million pounds for the year ending March 2026.
    It expects annual profits at the veterinary division to grow to 83 million pounds, despite an expected slowdown in sales growth "as customer cohorts reach a typical lull in activity".
  • Pre-Tax Profit and Analyst Consensus
    Pets at Home maintained its underlying pre-tax profit expectations for fiscal 2026, and said it was comfortable with analyst consensus expectations of around 99 million pounds for fiscal 2027.
  • Regulatory Environment
    The update comes as Britain's veterinary sector faces new regulatory requirements including price transparency measures and prescription fee caps, though Pets at Home said it expects no adverse impact from the changes.

($1 = 0.7579 pounds)

(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)

Key Takeaways

  • Turnaround plan (product, price, execution, cost) restored positive like‑for‑like growth in retail while delivering £20m in cost savings, with retail profit expected ~£30m for year ending March 2026
  • Veterinary division remains a profit engine, with underlying profit expected to reach £83m despite a growth slowdown
  • New CEO leadership and favorable outlook amid regulatory changes; reaffirmed FY26 pre‑tax profit guidance and alignment with analyst forecasts for FY27 (~£99m)

References

Frequently Asked Questions

How did the Pets at Home turnaround plan impact sales?
The turnaround plan helped return the retail business to positive like-for-like sales growth in the second half, with sequential improvement in the fourth quarter.
What measures did Pets at Home implement in its turnaround?
Pets at Home completed its 20-million-pound cost-savings target and made price investments focused on product, price, execution, and cost efficiency.
How is Pets at Home's veterinary division performing?
The veterinary division is expected to deliver profits of 83 million pounds, despite anticipating slower sales growth.
Will regulatory changes impact Pets at Home?
Pets at Home expects no adverse impact from new UK veterinary sector regulatory requirements such as price transparency and prescription fee caps.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category